AMBRA1 binds CUL4-DDB1 complex and targets D-type cyclins for ubiquitin-mediated degradation, thus acting as a tumor suppressor and assuring normal cell cycle progression [9, 39]. Here, AMBRA1 is linked to neoplasm.